• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Myomo Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    6/18/25 8:40:27 AM ET
    $MYO
    Industrial Specialties
    Health Care
    Get the next $MYO alert in real time by email
    8-K
    false000136929000013692902025-06-182025-06-18

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): June 18, 2025

    Myomo, Inc.

    (Exact Name of Company as Specified in Charter)

     

     

     

     

     

    Delaware

     

    001-38109

     

    47-0944526

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

     

    45 Blue Sky Dr., Suite 101

    Burlington, MA

     

    01803

    (Address of Principal Executive Offices)

     

    (Zip Code)

    Company’s telephone number, including area code: (617) 996-9058

    Not applicable

    (Former Name or Former Address, if Changed Since Last Report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

     

     

     

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, $0.0001 par value per share

     

    MYO

     

    NYSE American

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


     

    Item 7.01. Regulation FD Disclosure.

    As previously announced, on June 18, 2025, Myomo, Inc. (the "Company") will host an Investor & Analyst Day at 10:00 a.m. Eastern Time. During the course of the event, management will provide an in-depth overview of the Company's business model and discuss long-term financial aspirations. The event will be webcast and can be accessed here, and a reply of the webcast will be available following the event in the "Events and Presentations" section of the Company's investor website at ir.myomo.com.

    In connection with its Investor & Analyst Day, on June 18, 2025, the Company issued a press release providing highlights for the event, including elements of the Company's long term financial model. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

    The information included under Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

    Item 9.01.

    (d) Exhibits

    Exhibit
    No.

     

    Description

     

     

     

     

     

     

    99.1

     

    Press release issued by Myomo, Inc. on June 18, 2025 furnished herewith.

    104

     

    The cover page from the Company’s Form 8-K dated June 18, 2025, formatted in Inline XBRL

     

     

     

     


     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

     

     

     

     

    MYOMO, INC.

     

     

     

     

    Date:

    June 18, 2025

    By:

    /s/ David A. Henry

     

     

     

    David A. Henry
    Chief Financial Officer

     


    Get the next $MYO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MYO

    DatePrice TargetRatingAnalyst
    7/31/2024$7.00Buy
    Craig Hallum
    5/20/2024$7.00Buy
    Lake Street
    12/15/2023$6.50Buy
    H.C. Wainwright
    More analyst ratings

    $MYO
    SEC Filings

    View All

    SEC Form 10-Q filed by Myomo Inc.

    10-Q - MYOMO, INC. (0001369290) (Filer)

    8/11/25 4:15:27 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Myomo Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - MYOMO, INC. (0001369290) (Filer)

    8/11/25 4:15:33 PM ET
    $MYO
    Industrial Specialties
    Health Care

    SEC Form 144 filed by Myomo Inc.

    144 - MYOMO, INC. (0001369290) (Subject)

    6/30/25 8:12:58 PM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kirk Thomas F bought $55,000 worth of shares (50,000 units at $1.10), increasing direct ownership by 13% to 424,420 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    8/19/25 7:23:00 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Chief Executive Officer Gudonis Paul R bought $47,295 worth of shares (50,000 units at $0.95), increasing direct ownership by 4% to 1,259,013 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    8/18/25 7:51:17 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Chief Medical Officer Kovelman Harry covered exercise/tax liability with 13,054 shares, decreasing direct ownership by 8% to 140,618 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    7/2/25 8:20:13 AM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kirk Thomas F bought $55,000 worth of shares (50,000 units at $1.10), increasing direct ownership by 13% to 424,420 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    8/19/25 7:23:00 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Chief Executive Officer Gudonis Paul R bought $47,295 worth of shares (50,000 units at $0.95), increasing direct ownership by 4% to 1,259,013 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    8/18/25 7:51:17 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Director Kirk Thomas F bought $125,993 worth of shares (38,767 units at $3.25), increasing direct ownership by 13% to 344,700 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    5/15/25 4:53:28 PM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Craig Hallum initiated coverage on Myomo with a new price target

    Craig Hallum initiated coverage of Myomo with a rating of Buy and set a new price target of $7.00

    7/31/24 7:20:07 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Lake Street initiated coverage on Myomo with a new price target

    Lake Street initiated coverage of Myomo with a rating of Buy and set a new price target of $7.00

    5/20/24 9:00:38 AM ET
    $MYO
    Industrial Specialties
    Health Care

    H.C. Wainwright initiated coverage on Myomo with a new price target

    H.C. Wainwright initiated coverage of Myomo with a rating of Buy and set a new price target of $6.50

    12/15/23 8:26:14 AM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Myomo Reports Second Quarter 2025 Financial and Operating Results

    Revenue of $9.7 million 816 patients added to the MyoPro pipeline Updates 2025 revenue guidance Conference call begins today at 4:30pm Eastern time Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2025. Financial and operating highlights for the second quarter of 2025 include the following (all comparisons are with the second quarter of 2024 unless otherwise indicated): Revenue was $9.7 million, up 28%; 56% of revenue was from Medicare Part B patients. Reven

    8/11/25 4:05:00 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Myomo to Report Second Quarter 2025 Financial Results on August 11

    Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter of 2025 on Monday, August 11, 2025. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Participants are encouraged to pre-register for the conference call using this link to receive a dial-in number and PIN to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Th

    8/4/25 4:05:00 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Myomo Provides Highlights of Today's Investor & Analyst Day Event

    Senior executives to provide an in-depth review of the Company's business model and discuss long-range aspirational financial metrics Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will host an Investor & Analyst Day event today from 10 a.m. to 3 p.m. Eastern time during which management will provide an in-depth review of the Company's business model, provide a tour of its new headquarters and manufacturing facility and discuss long-range aspirational financial metrics. A live and archived webcast of the event is available here. To be held

    6/18/25 8:30:00 AM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Financials

    Live finance-specific insights

    View All

    Myomo Reports Second Quarter 2025 Financial and Operating Results

    Revenue of $9.7 million 816 patients added to the MyoPro pipeline Updates 2025 revenue guidance Conference call begins today at 4:30pm Eastern time Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2025. Financial and operating highlights for the second quarter of 2025 include the following (all comparisons are with the second quarter of 2024 unless otherwise indicated): Revenue was $9.7 million, up 28%; 56% of revenue was from Medicare Part B patients. Reven

    8/11/25 4:05:00 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Myomo to Report Second Quarter 2025 Financial Results on August 11

    Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter of 2025 on Monday, August 11, 2025. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Participants are encouraged to pre-register for the conference call using this link to receive a dial-in number and PIN to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Th

    8/4/25 4:05:00 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Myomo Provides Highlights of Today's Investor & Analyst Day Event

    Senior executives to provide an in-depth review of the Company's business model and discuss long-range aspirational financial metrics Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will host an Investor & Analyst Day event today from 10 a.m. to 3 p.m. Eastern time during which management will provide an in-depth review of the Company's business model, provide a tour of its new headquarters and manufacturing facility and discuss long-range aspirational financial metrics. A live and archived webcast of the event is available here. To be held

    6/18/25 8:30:00 AM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Leadership Updates

    Live Leadership Updates

    View All

    Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

    Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mira Kirti Sahney to Inogen's Board of Directors, effective January 31, 2025. The company also announced that Tom West, who has served as a director since April 2023, retired as a member of the Board of Directors, effective January 30, 2025. "We are thrilled to welcome Mira Sahney to the Inogen Board. Mira brings considerable management, technical, and operational experience in the medical device field to Inogen," said Elizabeth Mora, Chairperson of the Board. "Mira's appointment will further strengthen Inogen's Board with a

    2/3/25 4:00:00 PM ET
    $INGN
    $MDT
    $MYO
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus

    Myomo Appoints Heather Getz to its Board of Directors

    Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors. Ms. Getz brings more than 25 years of corporate experience creating long-term value through financial, general management, and healthcare leadership. She has significant expertise in finance, reimbursement, investor relations, compliance, M&A and strategic plannin

    3/28/24 4:05:00 PM ET
    $BFLY
    $MYO
    Medical Electronics
    Health Care
    Industrial Specialties

    Myomo Appoints Yitzchak Jacobovitz to its Board of Directors

    Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Yitzchak Jacobovitz as a Class II director effective January 27, 2023, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has six directors. Mr. Jacobovitz, 47, is currently a partner and lead healthcare analyst at AIGH Capital Management and affiliates ("AIGH"), where he has significantly grown AIGH's healthcare footprint since joining in 2014. Prior to AIGH, Mr. Jacobovitz was a managing director at Capstone, a policy research

    1/30/23 4:05:00 PM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Myomo Inc.

    SC 13G/A - MYOMO, INC. (0001369290) (Subject)

    10/18/24 2:21:35 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13G/A filed by Myomo Inc.

    SC 13G/A - MYOMO, INC. (0001369290) (Subject)

    7/12/24 10:35:49 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13G/A filed by Myomo Inc.

    SC 13G/A - MYOMO, INC. (0001369290) (Subject)

    7/11/24 6:02:07 PM ET
    $MYO
    Industrial Specialties
    Health Care